The Global market for Pre-Clinical Imaging is expected to reach $2.3 billion by the end of 2020 growing at a CAGR of around 12.9% from 2014 to 2021. Pre-Clinical Imaging is the visualization of living animals for research purposes, such as drug development. Imaging techniques which are non-invasive and in vivo are of specific important in pre-clinical imaging.
Translational research is changing the practice of modern therapeutics and the way in which the health issues are tackled and solved. The use of small animals in pre-clinical trials is a major milestone for these kinds of research and development. The main advantage of preclinical imaging are reduction in the biological variability. Combination of two technologies is used for target identification and drug development.
The major types of pre-clinical imaging techniques is standalone imaging technologies and multimodal imaging technologies. The Global Pre-Clinical Imaging Market is segregated on the basis of Technology (Ct, MRI, Ultrasound and Nuclear Imaging [PET and SPECT]), Reagents (Iodine, Fluorine, Carbon, Copper, Barium, Iron and Fluorescent Proteins) and Region (North America, Europe, Asia Pacific and Rest of the World).
Rise in the number of Contract Research Organizations (CRO), innovations in the devices used for small imaging and increasing number of drug trials due to rise in the incidences of chronic diseases are some of the factors augmenting the market growth.
Huge cost of equipment, lack of skilled personnel handle the equipment and lack of proper infrastructure are hindering the growth of the market.
What the report offers:
Market Definition for the specified topic along with identification of key drivers and restraints for the market.
Market analysis for the Global Pre-Clinical Imaging Market, with region specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
Identification and analysis of the Macro and Micro factors that affect the Global Pre-Clinical Imaging Market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
Manager – Partner Relations & International Marketing
Ph: +1-214-377-1121 (US)/ +44-020-3286-9338 (UK)